Event chart ENDO INTERNATIONAL PLC |
|
|
Upcoming events on ENDO INTERNATIONAL PLC |
|
05/11/23 | | Q1 2023 Earnings Release (Projected) |
08/09/23 | | Interim 2023 Earnings Release (Projected) |
11/09/23 | | Q3 2023 Earnings Release (Projected) |
02/28/24 | | FY 2023 Earnings Release (Projected) |
|
Past events on ENDO INTERNATIONAL PLC |
|
03/06/23 | 09:50am | | FY 2022 Earnings Release |
03/06/23 | | FY 2022 Earnings Call |
11/09/22 | 09:30am | | Q3 2022 Earnings Release |
11/09/22 | | Q3 2022 Earnings Call |
10/27/22 | | Fall Scientific Meeting |
10/10/22 | | American Society for Dermatologic Surgery Meeting |
08/09/22 | 09:45am | | Interim 2022 Earnings Release |
08/09/22 | | Interim 2022 Earnings Call |
06/09/22 | 04:00am | | Annual General Meeting |
05/11/22 | | Cosmetic Advances & Laser Education Symposium |
|
Past dividends on ENDO INTERNATIONAL PLC |
|
- No events available -
|
|
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 |
Sales M $ |
Released Forecast Spread | 2 947 2 899 1,7% | 2 914 2 881 1,2% | 2 903 2 797 3,8% | 2 993 2 943 1,7% |
Operating income (EBITDA) M $ |
Released Forecast Spread | 1 338 1 324 1,1% | 1 250 1 276 -2,0% | 1 360 1 322 2,8% | 1 481 1 427 3,7% |
Operating profit (EBIT) M $ |
Released Forecast Spread | 1 237 1 207 2,5% | 1 181 1 158 2,0% | 1 291 1 220 5,8% | 1 392 1 329 4,7% |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -939 -748 -26% | -345 617 -156% |
|
|
Net income M $ |
Released Forecast Spread | -1 031 -732 -41% | -423 -203 -108% | 184 -9,70 1 996% | -613 10,2 -6 112% |
EPS $ |
Released Forecast Spread | -4,29 -3,32 -29% | -1,87 -0,58 -222% | 0,79 0,75 6,0% | -2,63 1,38 -291% | Announcement Date | 02/28/2019 | 02/26/2020 | 02/25/2021 | 02/28/2022 |
|
|
Fiscal Period : December | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
Sales M $ |
Released Forecast Spread | 760 651 17% | 718 669 7,4% | 714 666 7,2% | 772 668 16% | 789 734 7,6% | 652 637 2,4% | 569 525 8,5% |
Operating income (EBITDA) M $ |
Released Forecast Spread | 344 287 20% | 365 302 21% | 343 322 6,4% | 387 288 34% | 387 337 15% | 311 273 14% | 160 127 27% |
Operating profit (EBIT) M $ |
Released Forecast Spread | 326 267 22% | 338 271 25% | 322 274 18% | 365 264 38% | 367 305 20% | 294 246 19% | 145 107 36% |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
| 47,8 129 -63% |
|
|
|
|
|
Net income M $ |
Released Forecast Spread | 119 4,70 2 439% | 41,5 36,8 13% | -15,5 30,2 -151% | -77,2 -1,26 -6 052% | -562 61,4 -1 015% | -72,0 9,00 -900% | -1 885 -121 -1 463% |
EPS $ |
Released Forecast Spread | 0,51 -0,22 332% | 0,17 -0,03 667% | -0,04
| -0,33 -0,02 -1 550% |
|
|
| Announcement Date | 02/25/2021 | 05/06/2021 | 08/05/2021 | 11/04/2021 | 02/28/2022 | 05/05/2022 | 08/09/2022 | |
|
|
Upcoming sector events for ENDO INTERNATIONAL PLC |
|
|
|
Past sector events for ENDO INTERNATIONAL PLC |
|
|
|
|
|
|
Novartis to pay $30 million to health plans, consumers over Exforge antitrust claims |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|